In Bauml et al., patients with oligometastatic (≤ 4 lesions) non-small cell lung cancer were treated with anti-PD-1 antibody and local treatment (surgery, RT, or radiofrequency ablation) for all lesions [89]. This evidence concerns the gene PDCD1 and non-small cell lung carcinoma.